Abstract:Objective To study the mRNA expression of survivin, a novel apoptosis inhibitor, and cell apoptosis and proliferation and MDR 1 in hepatocellular carcinoma (HCC) and investigate the effects of survivin mRNA expression on apoptosis and proliferation and MDR 1 in HCC. Methods RT PCR, TUNEL and SABC IHC were used to detect the expression of survivin mRNA and MDR 1 mRNA, cell apoptosis and the ki 67 expression, respectively, in samples from 31 cases of HCC. Meanwhile, the effects of survivin mRNA expression on cell apoptosis and proliferation and the relationship between survivin mRNA expression and MDR 1 mRNA expression were analyzed. Results The positive survivin mRNA expression was observed in 22 out of the 31 cases (71%). All the neighboring non tumor and cirrhotic tissues were completely negative for survivin mRNA expression. The apoptotic index (AI) was 0 4%～15% and the overall average was 4 24±3 92%. The average of AI was 4 64±4 30% in survivin mRNA positive cases and 3 36±2 98% in negative cases. There was no significant difference between the 2 groups of patients (P0 05). The ki 67 proliferation index (LI) was 2%～80% and the overall average was 26 21±14 9%. The average LI was 30 32±15 43% in the survivin mRNA positive cases and 17 56±9 44% in negative ones. The LI showed a significant positive correlation with the survivin mRNA expression (P0 05). The positive MDR 1 mRNA expression was 18/31 (58 05%) in HCC tissue. Amongst the 22 survivin mRNA positive cases, 15 were MDR 1 mRNA positive and 7 negative. As for the 9 survivin mRNA negative cases, 3 were MDR 1 mRNA positive and 6 negative. Conclusions Survivin may play an important role in the progression of HCC. There is no significant difference between survivin mRNA expression and AI. However, LI shows a significant positive correlation with the survivin mRNA expression. Though survivin is an apoptosis inhibiting agent, it does not significantly influence cell apoptosis in HCC, and it plays an important role in the progression and development of HCC by promoting cell proliferation. Survivin will be a potential new target of gene therapy in HCC. There is no significant correlation between survivin and MDR 1 expression. The formation of MDR in HCC is attributed to various kinds of pathway but not survivin.

A key regulator of mitosis and apoptosis:Survivin,as a novel target for anticancer drug therapeutics

Survivin as a Therapeutic Target for the Treatment of Human Cancer

Survivin Small Molecules Inhibitors: Recent Advances and Challenges

MicroRNA Regulation and Therapeutic Targeting of Survivin in Cancer.

A Study on the Expression of Survivin Gene in Human Gastric Cancer

Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target

The Role of Survivin in the Endometriosis

Effects of Survivin Mrna Expression on Apoptosis and Proliferation and MDR-1 in Hepatocellular Carcinoma

Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective

Discovering and Characterizing of Survivin Dominant Negative Mutants With Stronger Pro-apoptotic Activity on Cancer Cells and CSCs

Survivin (BIRC5): Implications in cancer therapy

Lentivirus-mediated Shrna Targeting XIAP and Survivin Inhibit SW1990 Pancreatic Cancer Cell Proliferation in Vitro and in Vivo.

Design, Synthesis And Structure-Activity Relationship Studies Of Novel Survivin Inhibitors With Potent Anti-Proliferative Properties

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

Expression of Survivin in Endometrial Cancer and Its Role in Regulating Apoptosis of Endometrial Cancer Cells

Survivin And Pancreatic Cancer

Pioneering 4,11-Dioxo-4,11-dihydro-1 H-anthra[2,3- d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy

The antiestrogenic effect of cigarette smoking in women.

The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells.

High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.

Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)